Physician profile
Diane E Macys
NPI 1760578256
$2,553.16
in general payments reported to CMS, 2019-2025
17 companies · $710 in 2025
The $710 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $171 · 2023: $906 · 2024: $766 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,381.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $543.73 | 2022-2025 | Descovy, Yeztugo, Epclusa |
| Madrigal Pharmaceuticals | $267.38 | 2024-2025 | Rezdiffra |
| Glaxosmithkline, LLC. | $216.70 | 2024-2025 | Blujepa |
| Impulse Dynamics (USA) INC. | $122.15 | 2023 | Optimizer |
| Eisai INC. | $122.07 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.93 | 2024 | Jardiance |
| Lilly USA, LLC | $119.71 | 2023 | Mounjaro |
| Kyowa Kirin, INC. | $119.17 | 2024 | |
| Heartflow, INC. | $116.45 | 2023 | Ffrct |
| Merck Sharp & Dohme LLC | $112.07 | 2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $110.26 | 2022 | |
| Mylan Specialty L.P. | $105.01 | 2023 | Yupelri |
| Alnylam Pharmaceuticals INC. | $104.62 | 2025 | Amvuttra |
| Otsuka America Pharmaceutical, INC. | $104.00 | 2023 | Jynarque |
| Acadia Pharmaceuticals INC | $102.64 | 2024 | Nuplazid |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $89.65 | 2024 | Vivitrol |
| Inspire Medical Systems, INC. | $75.62 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Macys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.